NYSE:TBI - Trueblue Stock Price, News, & Analysis

Trueblue trades on the New York Stock Exchange (NYSE) under the ticker symbol "TBI."

Trueblue declared that its Board of Directors has authorized a stock repurchase program on Tuesday, October 31st 2017, which allows the company to repurchase $100,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to repurchase shares of its stock through open market purchases. Stock repurchase programs are typically a sign that the company's board believes its stock is undervalued.

Trueblue Inc (NYSE:TBI) issued its quarterly earnings results on Monday, July, 30th. The business services provider reported $0.57 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.49 by $0.08. The business services provider earned $614.30 million during the quarter, compared to analyst estimates of $601.43 million. Trueblue had a return on equity of 14.66% and a net margin of 2.57%. The company's quarterly revenue was up .7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.42 EPS. View Trueblue's Earnings History.

Trueblue is scheduled to release their next quarterly earnings announcement on Monday, October, 29th 2018. View Earnings Estimates for Trueblue.

Trueblue updated its third quarter earnings guidance on Monday, July, 30th. The company provided earnings per share guidance of $0.75-0.81 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.75. The company issued revenue guidance of $662-677 million, compared to the consensus revenue estimate of $669.25 million.

3 analysts have issued 1-year price objectives for Trueblue's shares. Their predictions range from $28.00 to $31.00. On average, they expect Trueblue's stock price to reach $29.3333 in the next twelve months. This suggests a possible upside of 2.0% from the stock's current price. View Analyst Price Targets for Trueblue.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Trueblue in the last year. There are currently 3 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Trueblue.

Some companies that are related to Trueblue include Insperity (NSP), Dometic Group AB (publ) (DTCGF), AMN Healthcare Services (AMN), TTEC (TTEC), Kforce (KFRC), Kelly Services, Inc. Class B (KELYB), Kelly Services, Inc. Class A (KELYA), SThree (STREF), Barrett Business Services (BBSI), Cross Country Healthcare (CCRN), StarTek (SRT), DLH (DLHC), R C M Technologies (RCMT), Hudson Global (HSON) and Command Center (CCNI).

News coverage about TBI stock has been trending somewhat negative recently, according to Accern Sentiment. The research group rates the sentiment of press coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Trueblue earned a news and rumor sentiment score of 0.00 on Accern's scale. They also assigned press coverage about the business services provider an impact score of 47.27 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the near term. View Recent Headlines for Trueblue.

Trueblue's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (13.42%), Dimensional Fund Advisors LP (6.27%), FMR LLC (3.07%), Hood River Capital Management LLC (1.93%), Chartwell Investment Partners LLC (1.59%) and Acadian Asset Management LLC (1.45%). Company insiders that own Trueblue stock include Bonnie W Soodik, Derrek Lane Gafford, James E Defebaugh, Joseph P Sambataro Jr, Sean A Ebner, Steven C Cooper, Taryn R Owen and Wayne W Larkin. View Institutional Ownership Trends for Trueblue.

TBI stock was sold by a variety of institutional investors in the last quarter, including Royce & Associates LP, Renaissance Technologies LLC, Tocqueville Asset Management L.P., Algert Global LLC, Russell Investments Group Ltd., Chartwell Investment Partners LLC, Bank of New York Mellon Corp and BlueMountain Capital Management LLC. Company insiders that have sold Trueblue company stock in the last year include Bonnie W Soodik, James E Defebaugh, Joseph P Sambataro Jr, Sean A Ebner, Steven C Cooper, Taryn R Owen and Wayne W Larkin. View Insider Buying and Selling for Trueblue.

TBI stock was purchased by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP, Hood River Capital Management LLC, BlackRock Inc., American Century Companies Inc., LSV Asset Management, Acadian Asset Management LLC, James Investment Research Inc. and Heartland Advisors Inc.. View Insider Buying and Selling for Trueblue.

Shares of TBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of TBI stock can currently be purchased for approximately $28.75.

Trueblue has a market capitalization of $1.17 billion and generates $2.51 billion in revenue each year. The business services provider earns $55.45 million in net income (profit) each year or $1.74 on an earnings per share basis. Trueblue employs 5,500 workers across the globe.

Trueblue's mailing address is 1015 A STREET, TACOMA WA, 98402. The business services provider can be reached via phone at 253-383-9101 or via email at [email protected]